Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Allergan Medical |
---|---|
Information provided by: | Allergan Medical |
ClinicalTrials.gov Identifier: | NCT00443274 |
Ten year safety study examining rates of rare adverse events, child bearing issues, optimal mammography, and detection of ruptures in subjects with silicone or saline breast implants.
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Women with breast implants for augmentation, reconstruction, or revision of augmentation or reconstruction
Inclusion Criteria:
Exclusion Criteria:
Contact: Allergan Medical | devicetrials@allergan.com |
United States, Oregon | |
Recruiting | |
Eugene, Oregon, United States |
Study Director: | Allergan Medical | Allergan Medical |
Responsible Party: | Allergan ( Allergan Medical ) |
Study ID Numbers: | BIFS001 |
Study First Received: | March 1, 2007 |
Last Updated: | December 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00443274 |
Health Authority: | United States: Institutional Review Board |